Article Details
Retrieved on: 2024-01-17 12:31:15
Tags for this article:
Click the tags to see associated articles and topics
Summary
CordenPharma partners with pHLIP to enhance biotechnology by developing lipid nanoparticle (LNP) platforms for mRNA and gene therapy, harnessing lipid and peptide technology for targeted intracellular delivery, supported by a contract manufacturing organization (CMO).
Article found on: bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here